LifeStance Health Group, Inc. (LFST) stock
LFSTNasdaqServices-Health ServicesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/30143% above fair value
$14.15−0.22 (-1.53%)
Close on Nov 12, 2026Market cap $5.41BP/E 74.5Yield –
LifeStance Health ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
LifeStance Health's ebitda for the twelve months ending Sep 30, 2026 was $148.17M, up 205.4% year over year. For fiscal 2025 it was $65.77M, up 625.6% from the year before. The highest annual figure on record is $65.77M in fiscal 2025.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $65.77M | +625.6% |
| FY2024 | Dec 31, 2024 | $9.06M | – |
| FY2023 | Dec 31, 2023 | -$151.76M | – |
| FY2022 | Dec 31, 2022 | -$181.26M | – |
| FY2021 | Dec 31, 2021 | -$271.26M | -1583.9% |
| FY2019 | Dec 31, 2019 | $18.28M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $45.13M | +154.2% |
| Q2 FY2026 | Jun 30, 2026 | $41.96M | +445.7% |
| Q1 FY2026 | Mar 31, 2026 | $32.65M | +174.5% |
| Q4 FY2025 | Dec 31, 2025 | $28.43M | +154.4% |
| Q3 FY2025 | Sep 30, 2025 | $17.75M | +69.8% |
| Q2 FY2025 | Jun 30, 2025 | $7.69M | – |
| Q1 FY2025 | Mar 31, 2025 | $11.89M | – |
| Q4 FY2024 | Dec 31, 2024 | $11.18M | – |
| Q3 FY2024 | Sep 30, 2024 | $10.46M | – |
| Q2 FY2024 | Jun 30, 2024 | -$5.82M | – |
| Q1 FY2024 | Mar 31, 2024 | -$6.75M | – |
| Q4 FY2023 | Dec 31, 2023 | -$22.60M | – |
| Q3 FY2023 | Sep 30, 2023 | -$64.91M | – |
| Q2 FY2023 | Jun 30, 2023 | -$39.06M | – |
| Q1 FY2023 | Mar 31, 2023 | -$25.20M | – |
| Q4 FY2022 | Dec 31, 2022 | -$37.25M | – |
| Q3 FY2022 | Sep 30, 2022 | -$31.16M | – |
| Q2 FY2022 | Jun 30, 2022 | -$53.72M | – |
| Q1 FY2022 | Mar 31, 2022 | -$59.12M | -3521.5% |
| Q4 FY2021 | Dec 31, 2021 | -$108.31M | -2595.0% |
| Q3 FY2021 | Sep 30, 2021 | -$120.70M | -14021.9% |
| Q2 FY2021 | Jun 30, 2021 | -$43.98M | – |
| Q1 FY2021 | Mar 31, 2021 | $1.73M | – |
| Q3 FY2020 | Sep 30, 2020 | $4.34M | – |
| Q2 FY2020 | Jun 30, 2020 | $867.00K | – |
See a number that looks wrong?